Skip to search formSkip to main contentSkip to account menu

CG7870

Known as: CG-7870 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Use of a bioamplification assay to detect nonselective recombinants and assess the genetic stability of oncolytic adenoviruses.
Detection of nonselective adenoviruses in tissue- or tumor-selective oncolytic adenovirus preparations presents a technical… 
2004
2004
A Phase 1/11 trial of IV CG7870, a replication-selective, PSA-targeted oncolytic adenovirus (OAV), for the treatment of hormone-refractory, metastatic prostate cancer
3036 Background: CG7870 is a replication-selective OAV genetically engineered to preferentially replicate in prostate tissue.A… 
2004
2004
A Phase 1/11 trial of IV CG7870, a replication-selective, PSA-targeted oncolytic adenovirus (OAV), for the treatment of hormone-refractory, metastatic prostate cancer.
3036 Background: CG7870 is a replication-selective OAV genetically engineered to preferentially replicate in prostate tissue.A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)